“It might be that the FDA expects other agencies will take the lead on interoperability, and perhaps they are planning to play a more supportive role,” speculated Bradley Merrill Thompson, a lawyer with Epstein Becker Green and a representative of several industry groups supporting health IT. The FDA would likely be involved in issues surrounding interoperability between devices and software.

Still, he saw the FDA's other outlined priorities as positive for healthcare overall.